Immunopathogenesis of toxoplasmosis

Clinical and Experimental Medicine

Volumn 3, Issue 2, 2003, Pages 84-105

  Hegab, S M ^a   Al Mutawa, S A ^b  

^a Uveitis and External Disease Clinic   (Kuwait)

^b NONE

Author keywords

Atigen antibody; Ocular toxoplasmosis; Uveitis

Indexed keywords

ANTIPARASITIC AGENT; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; GATIFLOXACIN; HISTOCOMPATIBILITY ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN; MACROLIDE; MINOCYCLINE; PARASITE ANTIGEN; PYRIMETHAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINONE DERIVATIVE; RETINA ANTIGEN; ROXITHROMYCIN; SPIRAMYCIN; SULFADIAZINE; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM; UNINDEXED DRUG;

BRAIN INFECTION; CELLULAR IMMUNITY; CHORIORETINITIS; CLINICAL FEATURE; DISEASE COURSE; EYE INFECTION; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; LATENT PERIOD; MACROPHAGE; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; UVEITIS;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; HUMANS; MACROLIDES; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS;

FELIS CATUS; PROTOZOA; TOXOPLASMA GONDII;

EID: 0141884379     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-003-0011-2     Document Type: Review

References (411)

1. Nicolle C, Manceaux L (1908) Sur une infection a corps de Leishman (ou organisme voisin) du gondi. CR Acad Sci (Paris) 147:763-766
2. Nicolle C, Manceaux L (1909) Sur un protozoaire noveau de Gondi. Toxoplasma Arch Inst Pasteur (Tunis) 2:97-103
3. Siim JC, Biering-Sorenson U, Moller T (1963) Toxoplasmosis in domestic animals. Adv Vet Sci 8:335-429
4. Anonymous (1969) Toxoplasmosis: Report of a WHO meeting of investigators. Who Tech Rep Series 431:31
5. Jacobs L (1956) Propagation, morphology and biology of Toxoplasma. Ann NY Acad Sci 64:154-179
6. Stone WB, Manwell RD (1969) Toxoplasmosis in cold blooded hosts. J Protozool 16:99-102
7. Levine ND, Nye RR (1976) Toxoplasma ranae species from the leopard frog Rana pipiens Linnaeus. J Protozool 23:488-490
8. Kean BH (1972) Clinical toxoplasmosis: 50 years. Trans R Soc Trop Med Hyg 66:549-571
9. Feldman HA, Miller LT (1956) Serological study of toxoplasmosis prevalence. Am J Hyg 64:320-335
10. Kessel JF, Lewis WP, Jacobs L (1965) Toxoplasmic antibodies in Southern California and Polynesia. Hawaii Med J 25:141-144
11. Remington JS, Efron B, Cavanaugh E et al (1970) Studies on toxoplasmosis in El Salvador: prevalence and incidence of toxoplasmosis as measured by the Sabin-Feldman dye test. Trans R Soc Trop Med Hyg 64:252-267
12. Harboe A (1952) Toxoplasma titres in 1600 blood donors in Oslo. Acta Pathol Microbiol Scand 93[Suppl]:325-331
13. Couvreur J, Desmonts G (1962) Congenital and maternal toxoplasmosis. A review of 300 congenital cases. Dev Med Child Neurol 4:519-530
14. Doehring E, Reiter-Owana J, Bauer O et al (1995) Toxoplasma antibodies in pregnant women and their newborns in Dar es Salam, Tanzania. Am J Trop Med Hyg 52:546-548
15. Prawecka M, Dymowska Z, Salem SN (1971) Intradermal and indirect fluorescent antibody tests in the diagnosis of toxoplasmosis. J Kwt Med Assoc 5:31-38
16. Hall AJH, Ronehan MJ, Harper CA (1993) The etiology of ocular toxoplasmosis in Melbourne. Aust NZ J Ophthalmol 21:29-30
17. Johnson MW, Greven CM, Jaffe GJ et al (1997) Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48-57
18. Burnett AJ, Shortt SG, Issac-Renton J, King I, Werker D, Bowie W (1998) Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105:1032-1037
19. Ongkosuwito JV, Bosch-Driessen EH, Koppe JG, Kylstra A (1999) Congenital evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of infection. Am J Ophthalmol 128:407-412
20. Jones JL, Krieszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154:357-365
21. Desmonts G, Couvreur J, Alison F et al (1965) Etude epidemiologique sur la toxoplasmose de l'influence de la cuisson de viande de boucherie sur la frequence de l'infection humane. Rev Fr Etud Clin Biol 10:952-958
22. Luft BJ, Reminton JS (1984) Acute Toxoplasma infection among family members of patients with acute lymphadenopathic toxoplasmosis. Arch Intern Med 144:53-56
23. Cutinho SG, Morgado A, Wagner M et al (1982) Outbreak of human toxoplasmosis in a rural area. A three year serologic work-up study. Mem Inst Oswaldo Cruz 77:29-36
24. Hall SM (1992) Congenital toxoplasmosis: regular review. B M J 305:291-297
25. Ruiz A, Frenkel JK (1980) Toxoplasma gondii in Costa Rickan cats. Am J Trop Med Hyg 29:1150-1160
26. Frenkel JK, Ruiz A, Chinchilla M (1975) Soil survival of Toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 24:439-443
27. Dubey JP, Miller NL, Frenkel JK (1970) Characterization of the new fecal form of Toxoplasma gondii. J Parasitol 56:447-456
28. Miller NL, Frenkel JK, Dubey JP (1972) Oral infections with Toxoplasma cysts and oocysts in felines, other mammals and birds. J Parasitol 58:928-937
29. Sumyuen MH, Garin YJ, Derouin F (1995) Early kinetics of toxoplasma infection in mice infected orally with cysts of an avirulent strain. J Parasitol 81:327-329
30. Coutinho SG, Lobo R, Dutra G (1982) Isolation of Toxoplasma from the soil during an outbreak of toxoplasmosis in a rural area of Brazil. J Parasitol 68:866-868
31. Dubey JP (1974) Effect of freezing on the infectivity of Toxoplasma cysts to cats. J Am Vet Med Assoc 165:534-536
32. Jadin JM, Creemers J (1968) Ultrastructure et biologie des toxoplasmes. III Observantions de toxoplasmes intraerythrocytaires chez un mammifare. Acta Trop (Basel) 25:267-270
33. Lainson R (1958) Observations on the development and nature of pseudocysts and cysts of Toxoplasma gondii. Trans R Soc Trop Med Hyg 52:369-407
34. Ferguson DJP (1988) An immune-electron microscopic study of tissue cyst of Toxoplasma gondii in mouse brain. Inst Phys Conf Ser 3:207-208
35. Sadak A, Taghy Z, Fortier B, Dubremetz JF (1988) Characterization of a family of rhoptry proteins of Toxoplasma gondii. Mol Biochem Parasitol 3:207-208
36. Ogino N, Yondeda C (1966) The fine structure and mode of division of Toxoplasma gondii. Arch Ophthalmol 75:218-227
37. Nichols BA, Chiapino ML (1987) Cytoskeleton of Toxoplasma gondii. J Parasitol 34:217-226
38. Ngo HM, Hoppe HC, Joiner KA (2000) Differential sorting and post-secretory targeting of proteins in parasitic invasion. Trends Cell Biol 10:67-72
39. Carruthers VB, Sibley LD (1997) Sequential protein from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Biol 73:114-123
40. Carruthers VB (2002) Host cell invasion by opportunistic pathogen Toxoplasma gondii. Acta Trop 81:111-122
41. Lycke E, Norrby R, Remington JS (1968) Penetration-enhancing factor extracted from Toxoplasma gondii which increases its virulence in mice. J Bacteriol 96:785-788
42. Norrby R, Lycke E (1967) Factors enhancing the host cell penetration of Toxoplasma gondii. J Bacteriol 93:53-58
43. Lycke E, Carlberg K, Norrby R (1975) Interactions between Toxoplasma gondii and its host cells: function of the penetration-enhancing factor of Toxoplasma. Infect Immun 11:853-861
44. Nichols BA, Chiapino ML, O'Connor GR (1983) Secretion from the rhoptries of Toxoplasma gondii during host cell invasion. J Ultrastruct Res 83:85-98
45. Sheffield HG, Melton ML (1968) The fine structure and reproduction of Toxoplasma gondii. J Parasitol 58:209-226
46. Hakansson H, Morisaki H, Heusser J, Sibley LD (1999) Time-lapse video microscopy of gliding motility in Toxoplasma gondii reveals a novel, biphasic mechanism of cell locomotion. Mol Biol Cell 10:3539-3547
47. King CA (1988) Cell motility of sporozoan protozoa. Parasitol Today 4:315-319
48. Hirai K, Hirato K, Yanagawa R (1966) A cinematographic study of the penetration of cultured cells by Toxoplasma gondii. Jpn J Vet Res 14:81-99
49. Aikawa M, Komata Y, Asai T, Modirokawa O (1977) Transmission and scanning electron microscopy of host cell entry by Toxoplasma gondii. Am J Pathol 87:285-295
50. Nichols BA, O'Connor GR (1981) Penetration of mouse pertoneal macrophages by the protozoan Toxoplasma gondii. Lab Invest 44:324-355
51. Nguyen BT, Stadtsbaeder S (1979) Modes d'enteree des trophozoites de Toxoplasma gondii dans les macrophages peritoneaux de souris normals, et dans les cellules Hela en culture. Une etude microcinematographique en contraste de phase. Z Parasitenkd 60:135-146
52. Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I (1990) Toxoplasma gondii fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science 249:641-646
53. Jones TC, Yeh S, Hirsch JG (1972) The interaction between Toxoplasma gondii and mammalian cells. I. Mechanism of entry and intracellular fate of the parasite. J Exp Med 136:1157-1172
54. Mordeu DG, Desai N, Dustin M, Sibley LD (1999) Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J Exp Med 190:1783-1792
55. Mordeu DG, Sibley LD (1997) Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanisms of entry. J Immunol 159:4452-4459
56. Nichols BA, Chiappino ML, O'Connor GR (1983) Secretion from the rhoptries of Toxoplasma gondii during host-cell invasion. J Ultrastruct Res 83:85-98
57. Stagno S, Dykes AC, Amos CS, Head RA, Juranek DD, Walls K (1980) An outbreak of toxoplasmosis related to cats. Pediatrics 65:706-712
58. Fleek DG (1969) Toxoplasmosis. Public Health 83:131
59. Jacobs L, Moyle GG, Ris RR (1963) The prevalence of toxoplasmosis in New Zealand sheep and cattle. Am J Vet Res 24:673-675
60. Jacobs L, Remington JS, Melton ML (1960) A survey of meat samples from swine, cattle and sheep for the presence of encysted toxoplasma. J Parasitol 46:23-28
61. Work K (1967) Isolation of Toxoplasma gondii from the flesh of sheep, swine and cattle. Acta Pathol Microbiol Scand 71:296-306
62. Jacobs L, Melton ML (1966) Toxoplasmosis in chickens. J Parasitol 52:1158-1162
63. Pande PG, Shukka RR, Sekariah PC (1961) Toxoplasma from the eggs of domestic fowl (Gallus gallus). Science 52:648
64. Remington JS, Jacobs L, Melton ML (1961) Congenital transmission of toxoplasmosis from mother animals with acute and chronic infection. J Infect Dis 108:163-173
65. Sanger VL, Chamberlain DM, Chamberlain KW et al (1953) Toxoplasmosis. V. Isolation of toxoplasma from cattle. J Am Med Assoc 123:87-91
66. Holland GN (1999) Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 128:502-505
67. Raisanen S (1978) Toxoplasmosis transmitted by blood transfusions. Transfusion 18:329-332
68. Kimball AC, Kean BH, Kellner A (1965) The risk of transmitting toxoplasmosis by blood transfusion. Transfusion 5:447-451
69. Siegal SE, Lunde MN, Gelderman AH et al (1971) Transmission of toxoplasmosis by leukocyte transfusion. Blood 37:388-394
70. Slavin M, Meyers JD, Remington JS, Hackman RC (1994) Toxoplasma gondii in bone marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 13:549-557
71. Remington JS, Gentry LO (1970) Acquired toxoplasmosis: infection versus disease. Ann NY Acad Sci 174:1006-1017
72. Morkvart K, Rehnova M, Ostrovska A (1978) Laboratory epidemic of toxoplasmosis. J Hyg Epidemiol Microbiol (Praha) 22:477-484
73. Cathie IAG (1954) Toxoplasmosis in childhood. Lancet 1:813-814
74. Saari M, Raisanen S (1974) Transmissions of acute toxoplasmosis infection. The survival of trophozoites in human tears, saliva and urine and in cat milk. Acta Ophthalmol (Copenh) 52:847-852
75. Scorich DN, Chiappino ML, Nichols RA (1989) Invasion of the guinea pig conjunctiva by Toxoplasma gondii. Invest Ophthalmol Vis Sci 29:1871-1880
76. Hall SM (1992) Congenital toxoplasmosis-regular review. BMJ 305:291-296
77. Desmonts G, Couvreur J (1974) Toxoplasmosis in pregnancy and its transmission to the fetus. Bull BY Acad Med 50:146-159
78. Remington JS, McLeod R, Desmonts G (1995) Toxoplasmosis. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 4th ed. Saunders, Philadelphia, pp 140-260
79. Desmonts G, Remington JS, Couvreur J (1987) Congenital toxoplasmosis. In: Stern L, Vert P (eds) Neonatal medicine. Masson, New York, pp 662-678
80. Loewer-Sieger DH, Rothova A, Koppe JG, Kijlstra A (1984) Congenital toxoplasmosis: a prospective study based on 1821 pregnant women. In: Saari KM (ed) Uveitis update. x, Amsterdam, pp 203-207
81. Wilson CB, Remington JS, Stagno S, Reynold DW (1980) Development of adverse sequelae in children born with subclinical toxoplasma infection. Pediatrics 66:767-774
82. Stray-Pedersen B (1992) Treatment of toxoplasmosis in pregnant mother and newborn child. Scand J Infect Dis 84[Suppl]:23-31
83. Perkins ES (1973) Ocular toxoplasmosis. Br J Ophthalmol 57:1-7
84. Langer H (1963) Repeated congenital infection with Toxoplasma gondii. Obstet Gynecol 21:318-329
85. Howe DK, Sibley LD (1995) Toxoplasma gondii comprise three clinical lineages: correlation of the parasite genotype with human disease. J Infect Dis 175:1561-1566
86. Dollfus H, Dureau P (1998) Congenital toxoplasma chorioretinitis transmitted by preconceptionally immune women. Br J Ophthalmol 82:1444-1448
87. Fortier R, Aissa E, Ajana F et al (1991) Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet 338:444
88. Koppe JG, Kloosterman GJ, Roever-Bonnet H de, Eckert-Stoink JA, Loewer-Sieger DH, Braijue JI de (1974) Toxoplasmosis and pregnancy, with a long-term follow-up of the children. Eur J Obstet Gynecol Reprod Biol 413:101-110
89. Couvreur J, Desmonts G, Tournier G, Szusterkac M (1984) Study of a homogenous series of 210 cases of congenital toxoplasmosis in infants aged 0 to 11 month detected prospectively. Ann Pediatr (Paris) 31:815-819
90. Couvreur J, Desmonts G, Aron-Rosa D (1984) Le prognostic oculaire de la toxoplasmose congenitale role du traitment. Ann Pediatr (Paris) 31:855-858
91. Koppe JG, Loewer-Sieger DH, Roever-Bonnet H de (1986) Results of 20 years follow-up of congenital toxoplasmosis. Lancet I:254-256
92. Mets MB, Toxoplasmosis Collaborative Study Group (1992) Ophthalmologic findings in congenital toxoplasmosis (abstracts). Invest Ophthalmol Vis Sci 33[Suppl]:1094
93. Patel DV, Holfols EM, Vogel NP, Boyer KM, Mets MB, Swisher CN et al (1996) Resolution of intracranial calcification in infants with treated congenital toxoplasmosis. Radiology 199:433-440
94. Nussenblatt RB, Belfort R Jr (1994) Ocular toxoplasmosis: an old disease revisited. JAMA 271:304-307
95. Woods AC, Burgess (1961) Endogenous inflammations of the uveal tract. Williams and Wilkins, Baltimore, pp 360-369
96. Reiger H (1951) Zur Klinik der im Erwachsenenalter erworbenen Toxoplasmose. Klin Monatsbl Augenheilkd 119:459-476
97. Wilder HC (1952) Toxoplasma chorioretinitis in adults; a preliminary study of forty-one cases diagnosed by microscopic examination (letter). Arch Ophthalmol 47:425
98. Wilder HC (1952) Toxoplasma chorioretinitis in adults. Arch Ophthalmol 48:127-136
99. Glasner PD, Silveira C, Kruzon-Moran D et al (1992) An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 114:136-144
100. Silveira C, Belfort R Jr, Burnier M et al (1988) Acquired toxoplasmosis infection as a cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106:362-364
101. Melamed J, Sebben JC, Maestri M et al (1993) Epidemiology of ocular toxoplasmosis in Rio Grande do Sul, Brazil. In: Dernouchamps JP, Verougstraete C, Caspers-Velu L (eds) Recent advances in uveitis. Proceedings of the Third International Symposium on Uveitis, Brussels, Belgium, Kugler, Amsterdam
102. Couvreur J, Desmonts G, Aron-Rosa D (1984) La prognostic oculaire de la toxoplasmose congenitale: role du traitment: communication prelimainaire. Ann Pediatr (Paris) 31:855-858
103. De Vroede M, Piepz A, Dodoin J, Verougstraete C, De Meuter F (1979) Congenital toxoplasmosis: late appearance of retinal lesions after treatment. Acta Paediatr Scand 68:761-762
104. Gilbert RE, Stanford MR (2000) Is ocular toxoplasmosis caused by prenatal or postnatal infection. Perspective. Br J Ophthalmol 84:224-226
105. Desmonts (1966) Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76:383-386
106. De Boer GH, Verhagen C, Buinenberg M et al (1996) Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 121:650-658
107. Araujo FG, Remington JS (1972) Immune response to intracellular parasite: suppressison by antibody. Proc Soc Biol Med 139:254-257
108. Krahenbuhl JL, Gaines JD, Remington JS (1972) Lymphocyte transfusion in human toxoplasmosis. J Infect 125:283-288
109. Anderson SE Jr, Krahenbuhl JL, Remington JS (1979) Longitudinal studies in lymphocyte response to toxoplasma antigen in human infected with T. gondii. J Clin Lab Immunol 2:293-297
110. Frenkel JK (1961) Pathogenesis of toxoplasmosis with consideration of cyst rupture in Besnoitia infection. Surv Ophthalmol 6:799-825
111. Tabbara KF (1986) Ocular toxoplasmosis. In: Tabbara KF, Hynduik RA (eds) Infections of the eye. Little Brown, Boston, pp 635-652
112. Miller MJ, Aronson WJ, Remington JS (1969) Late parasitemia in asymptomatic acquired toxoplasmosis. Ann Intern Med 71:139-145
113. Roit IM (1997) Roitt's essential immunology. Blackwell, London, pp 276-281
114. O'Connor GR (1983) Factors related to the initiation and recurrence of uveitis. 15th Edward Jackson Memorial Lecture. Am J Ophthalmol 98:577-599
115. Sabin AB (1956) Human toxoplasmosis: with special reference to intraocular inflammation: a critical review. The Sixth William Hamlin Wilder Memorial Lecture. Am J Ophthalmol 41:600-606
116. Rao NA, Font RL (1977) Toxoplasmic retinochoroiditis: electron-microscopic and immunofluorescence studies of formalin-fixed tissues. Arch Ophthalmol 95:273-277
117. Wyler DJ, Blackman HJ, Lunde MN (1980) Cellular hypersensitivity to toxoplasmal and retinal antigens in patients with toxoplasmal retinochoroiditis. Am J Trop Med Hyg 29:1181-1186
118. Nussenblatt RB, Mittal KK, Fuhrman S, Sharma D (1989) Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol 107:632-641
119. Pavesio CE, Lightman S (1996) Toxoplasma gondii and ocular toxoplasmosis: pathogenesis (review). Br J Ophthalmol 80:1099-1107
120. Whittle RM, Wallace GR, Whiston RA et al (1993) Human retinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82:1017-1021
121. Gomez-Marin JE, Pinon JM, Bobhomme A, Guenounou M (1997) Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Med Hypotheses 48:161-169
122. Pavia CS (1986) Protection against experimental toxoplasmosis by adoptive immunotherapy. J Immunol 37:2985-2990
123. Monroy FP, Banerjee SK, Duong T, Aviles H (1999) Cold stress induced modulation of inflammatory responses and intracerebral cytokine mRNA expression in acute murine toxoplasmosis. J Parasitol 85:878-886
124. O'Connor GR (1983) Factors related to the initiation and recurrence of uveitis. 15th Edward Jackson Memorial Lecture. Am J Ophthalmol 96:577-599
125. Bosch-Driessen LH, Plaisier MB, Stilma JS, Van der Lelij A, Rothova A (2002) Reactivation of ocular toxoplasmosis after cataract extraction. Ophthalmology 109:41-45
126. Holst A, Ralfsen W, Svensson B et al (1993) Formation of free radicals during phacoemulsification. Curr Eye Res 12:359-365
127. Ward PA, Warren JS, Johson KJ (1988) Oxygen radicals, inflammation, and tissue injury. Free Radic Biol Med 5:403-408
128. Blake DR, Allen RE, Lunec J (1987) Free radicals in biological systems-a review oriented to inflammatory process. Br Med Bull 43:371-385
129. Nozik RA, O'Connor GR (1970) Studies on experimental ocular toxoplasmosis in the rabbit. II. Attempts to stimulate recurrences by local trauma, epinephrine, and corticosteroids. Arch Ophthalmol 84:788-791
130. Frenkel JK (1955) Ocular lesions in hamsters with chronic Toxoplasma and Besnoitia infection. Am J Ophthalmol 39:203-225
131. Frenkel JK (1965) Toxoplasmic retinochoroiditis. Arch Ophthalmol 73:304-306
132. Schlaegel TF Jr (1978) Ocular toxoplasmosis and pars planitis. Grune and Stratton, New York, pp 127-134
133. Nozik RA, O'Connor GR (1970) Studies on experimetal toxoplasmosis in the rabbit. I. The effect of antigenic stimulation. Arch Ophthalmol 83:724-728
134. Nozik RA, O'Connor GR (1971) Studies on experimental ocular toxoplasmosis in rabbits. Arch Ophthalmol 85:718-722
135. O'Connor GR (1970) The influence of hypersensitivity on the pathogenesis of ocular toxoplasmosis. Trans Am Ophthalmol Soc 68:501-547
136. O'Connor GR (1983) Ocular toxoplasmosis. Trans Am Ophthalmol Soc 81:108-121
137. Black MW, Boothroyd JC (2000) Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 64:607-623
138. Endo T, Sethi KK, Pierkarski G (1982) Toxoplasma gondii: calcium ionophore A23187-mediated exit of trophozoites from infected murine macrophages. Exp Parasitol 53:179-188
139. Stommel EW, Ely KH, Schwartzmann JD, Kasper LH (1997) Toxoplasma gondii: dithiol-induced Ca2+ flux causes egress of parasites from parasitophorous vacuole. Exp Paraitol 87:88-97
140. Kaufman HE (1961) Experimental ocular toxoplasmosis. Surv Ophthalmol 6:877-882
141. Rothova A, Meenken C, Buitenhuis HJ, Brinkman CJ, Naarsma GS et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517-523
142. Lakhanpal V, Schoket SS, Nirankari VS (1983) Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol 95:605
143. Ghosh M, Levy PM, Leopold IH (1965) Therapy of toxoplasmic uveitis. Am J Ophthalmol 59:55
144. Canamucio CJ, Hallett JW, Leopold IH (1963) Recurrence of toxoplasmic uveitis. Am J Ophthalmol 55:1035
145. Bosh-Driessen EH, Rothova A (1999) Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128:421-425
146. Culbertson WW, Tabbara KF, O'Connor GR (1982) Experimental ocular toxoplasmosis in primates. Arch Ophthalmol 100:321-325
147. Newman PE, Ghosheh R, Tabbara KF et al (1982) The role of hypersensitivity reactions to Toxoplasma antigens in experimental ocular toxoplasmosis in non-human primates. Am J Ophthalmol 94:159-164
148. Webb RM, Tabbara KF, O'Connor GR (1984) Retinal vasculitis in ocular toxoplasmosis in non-human primates. Retina 4:182-188
149. Brezin AP, Kasner L, Thulliez P, Li Q, Daffas F, Nussenblatt RB et al (1994) Ocular toxoplasmosis in the fetus: immunohistochemistry analysis and DNA amplification. Retina 14:19-26
150. Araujo FG, Remington JS (1980) Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis 141:144-149
151. Beverly JKA (1959) Congenital transmission of toxoplasmosis through successive generations of mice. Nature 183:1348-1349
152. Wilson CB, Remington JS (1980) What can be done to prevent congenital toxoplasmosis. Am J Obstet Gynecol 138:357-363
153. Markell EK, John DT, Krotoski WA (1999) Medical parasitology, 8th ed. Saunders, Philadelphia, pp 160-171
154. Luft BJ, Remington JS (1988) AIDS commentary. Toxoplasmic encephalitis. J Infect Dis 157:1-6
155. Cochereau-Massin I, Le Hoang P, Loutier-Frau, Zazoun L, Robinet M, Marcel P et al (1992) Ocular toxoplasmosis in human immunodeficiency virus infected patients. Am J Ophthalmol 114:130
156. Suzuki Y, Wong WY, Grumet FC et al (1996) Evidence of genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 173:265-268
157. Darrel RW, Peiper S, Kurland LT, Jacobs L (1964) Chorioretinopathy and toxoplasmosis. Arch Ophthalmol 71:63-68
158. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Jr M, Silveira S et al (1992) An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 114:136-144
159. Ware PL, Kasper LH (1987) Strain-specific antigens of Toxoplasma gondii. Infect Immun 55:778-783
160. Bohne W, Gross U, Heeseman J (1993) Differentiation between mouse-virulent and avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen. J Clin Microbiol 31:1641-1643
161. Darde ML, Bouteille B, Pestre-Alexandre M (1992) Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implication. J Parasitol 78:786-794
162. Cristina N, Oury B, Ambroise-Thomas P, Santoro F (1991) Restriction fragment length polymorphisms among Toxoplasma gondii strains. Parasitol Res 77:266-268
163. Sibley LD, Boothroyd JC (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82-85
164. Parmley SF, Gross U, Sucharezuk A, Windeck T, Sgarlato GD, Remington JS (1994) Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii. J Parasitol 80:293-301
165. Guo ZG, Johnson AM (1995) Genetic characterization of Toxoplasma gondii strains by random amplified polymorphic DNA polymerase chain reaction. Parasitology 111:127-132
166. Howe DR, Sibley D (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561-1566
167. Derouin F, Garin YJF (1991) Toxoplasma gondii: blood and tissue kinetics during acute and chronic infection in mice. Exp Parasitol 73:460-468
168. Sumyuen MH, Garin YJF, Derouin F (1995) Early kinetics of Toxoplasma gondii infection in mice orally infected with cysts of an avirulent strain. J Parasitol 81:327-329
169. Suzuki Y, Joh K, Orellana M, Conley FK, Remington JS (1991) A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739
170. Hunter CA, Roberts CW, Alexander J (1992) Kinetics of cytokine mRNA production in the brain of mice with progressive toxoplasmic encephalitis. Eur J Immunol 22:2317-2322
171. McLeod R, Skamene E, Brown CR, Eisenhauer P, Mack DG (1989) Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AxB/Bx4 recombinant and B10 congenic mice. J Immunol 143:3031-3034
172. Suzuki Y, Joh K (1994) Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma. Parasitol Res 80:125-130
173. Grigg ME, Bonnefoy S, Hehl AB, Boothroyd JC (2001) Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294:161-165
174. Kasper LH (1989) Identification of stage-specific antigens of Toxoplasma gondii. Infect Immun 57:668-672
175. Decoster A, Darcy F, Caron A, Capron A (1988) IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet II:1104-1107
176. Santoro F, Afchain D, Pierce JR, Cesborn JY, Ovlaque G, Capron A (1985) Serodiagnosis of Toxoplasma infection using a purified parasite protein (P30). J Clin Exp Immunol 62:262-269
177. Omata Y, Igarashi M, Ramos MI, Nakabayashi T (1989) Antigenic differences between endozoites and cystozoites defined by monoclonal antibodies. Parasitol Res 75:189-193
178. Woodison G, Smith JE (1990) Identification of dominant cyst antigens of Toxoplasma gondii. Parasitology 100:389-392
179. Lunde MN, Jacobs L (1983) Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol 69:806-811
180. Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC (1988) Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol 141:3584-3591
181. Kasper LH, Currie KM, Bradley MS (1985) An unexpected response to vaccination with pacified major membrane tachyzoite antigen (P30) of Toxoplasma gondii. J Immunol 134:3426-3431
182. McHugh TD, Ramsay ARC, James EA, Mognie R, Gillespie SH (1995) Pitfalls of PCR: misdiagnosis of cerebral nocardia infection (letter). Lancet 46:1436
183. Remington JS, Araujo FG, Desmonts G (1985) Recognition of different toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J Infect Dis 152:1020-1024
184. Santora F, Afchain D, Pierce R, Cesborn JY, Ovlaque G, Capron A (1985) Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol 62:262-269
185. Sharma SD, Mullen J, Araujo FG, Erlich HA, Remington JS (1983) Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 131:977-983
186. Bullow R, Boothroyd JC (1991) Protection of mice from fatal Toxoplasma gondii by immunization with P30 antigens in liposomes. J Immunol 147:2818-2820
187. Kasper, Currie KM, Bradley MS (1985) An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii. J Immunol 130:2407-2412
188. Kasper LH, Crabb H, Pfefferkorn ER (1983) Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. J Immunol 130:2407-2412
189. Jones CD, Okhravi N, Adamson P, Tasker S, Lightman (2000) Comparison of PCR detection method for B1, P30 and 18S rDNA genes of T. gondii in aqueous humor. Invest Ophthalmol Vis Sci 41:634-644
190. Darcy F, Charif H, Caron H et al (1990) Identification and biochemical characterization of antigens of tachyzoites and bradyzoites of Toxoplasma gondii with cross-reactive epitopes. Parasitol Res 76:473-478
191. Potasman T, Araujo FG, Desmonts F, Remington JS (1986) Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection. J Infect Dis 154:650-657
192. Sharma SD, Araujo FG, Remington JS (1984) Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii. J Immunol 133:2818-2820
193. Klaren V, Doornik C, Ongkosuwito J, Feron E, Kijlstra A (1998) Differences between intraocular and serum responses in patients with ocular toxoplasmosis. Am J Ophthalmol 126:698-706
194. Parmley SF, Sgarlato GD, Remington JS (1993) Genomic and corrected cDNA sequence of the P28 gene from Toxoplasma gondii. Mol Biochem Parasitol 57:161-165
195. Gazzinelli RT, Denkers EY, Sher A (1993) Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intra-cellular parasites. Infect Agents Dis 2:139-149
196. McDevitt HO, Chinitz A (1969) Genetic control of antibody response: relationship between immune response and histocompatibility (H-2) type. Science 163:1207-1208
197. Jones TC, Erb P (1985) H-2 complex linked resistance in murine toxoplasmosis. J Infect Dis 15:739-741
198. Suzuki Y, John K, Orellana MA, Conley FK, Remington JS (1991) A gene(s) within the H-2 D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732
199. Brown CR, McLeod R (1990) Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol 145:3438-3441
200. McLeod R, Eisenhower P, Mack DG, Filice G, Spitalny G (1989) Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J Immunol 142:3247
201. Brown CR, Hunter CA, Estes RG et al (1995) Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428
202. Parker SJ, Roberts CW, Alexander J (1991) CD8+ T cells and the major lymphocyte population involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol 84:497
203. Gazzinelli RT, Eltoum I, Wynn TA, Sher A (1993) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 52:1856
204. Khan IA, Ely KH, Kasper LH (1994) Antigen-specific CD8+ T cell clone protect against acute Toxoplasma gondii infection in mice. J Immunol 152:1858
205. Mack DG, Johnson JJ, Roberts F et al (1999) HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 59:193-200
206. Suzuki Y, Wong SY, Grumet FC et al (1996) Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 173:265-268
207. Meenken C, Rothova A, Waal LP de et al (1995) HLA typing in congenital toxoplasmosis. Br J Ophthalmol 79:494-497
208. Ohno S, O'Connor GR, Kimura SJ (1977) HLA antigens and toxoplasmic retinochoroiditis. Tohuku J Exp Med 123:91-94
209. Irescu H, Mathur WU, Skovron ML et al (1992) HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 5:37-45
210. Nussenblatt RB, Gery I, Ballintine EJ, Wacker WB (1980) Cellular immune responsiveness of patients to retinal S-antigen. Am J Ophthalmol 89:173
211. Smet MD de, Yamato JH, Machizuki M et al (1990) Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 110:135
212. Wacker WB, Donoso LA, Kalsow CM et al (1989) Experimental allergic uveitis. Isolation, characterization and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 143:79
213. Nussenblatt RB, Whitcup SM, Palestine (1996) Uveitis: fundamentals and clinical practice, 2nd ed. Mosby, St Louis, pp 31-34
214. Nozik RA, O'Connor GR (1970) Studies on experimental ocular toxoplasmosis in the rabbit. I. The effect of antigenic stimulation. Arch Ophthalmol 83:724-728
215. Newman PE, Ghosheh R, Tabbara KF et al (1982) The role of hypersensitivity reactions to toxoplasma antigens in experimental toxoplasmosis in nonhuman primates. Am J Ophthalmol 94:159-164
216. Dutton GN, Hay J (1983) Toxoplasmic retinochoroiditis: current concepts of pathogenesis. Trans Ophthalmol Soc UK 103:503-507
217. Dutton GN, McMnamin PG, Hay J, Cameron S (1986) The ultrasound pathology of congenital toxoplasmic chorioretinitis. II. The morphology of inflammatory changes. Exp Eye Res 43:545-560
218. Yoshizumu M (1976) Experimental toxoplasma retinitis. A light and electron microscopical study. Arch Path Lab Med 43:487-490
219. Ashton N (1979) Ocular toxoplasmosis in wallabies (Macropus rufogriseus). Am J Ophthalmol 88:322-332
220. Nussenblatt RB, Whitcup SM, Palestine AG (1996) Ocular toxoplasmosis. In: Uveitis: fundamentals and clinical practice, 2nd ed. Mosby, St. Louis, pp 211-228
221. Wyler DJ, Blackman JH, Lunde MN (1980) Cellular hypersensitivity to toxoplasmal and retinal antigens in patients with toxoplasmal retinochoroiditis. Am J Trop Med Hyg 29:1181-1186
222. Abrahams IW, Gregerson DS (1982) Longitudinal study of serum antibody responses to retinal antigens in acute ocular toxoplasmosis. Am J Ophthalmol 93:224-231
223. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR (1998) Human antiretinal antibodies in Toxoplasma retinochoroiditis. Br J Ophthalmol 82:1017-1021
224. Kijlstra A, Hoekzema R, Lelij A vander, Dockers G, Rothova A (1990) Humoral and cellular immune reactions against retinal antigens in clinical disease. Curr Eye Res 9[Suppl]:85-89
225. Brezin AP, Egwuagu CE, Silveira C et al (1991) Analysis of aqueous humor in ocular toxoplasmosis. N Engl J Med 324:699
226. Jacobiec FA, Lefkowitch J, Knowles DM (1984) B- and T-lymphocytes in ocular disease. Ophthalmology 91:635-654
227. Roberts F, Roberts CW, Ferguson DJ, Mcleod R (2000) Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol 22:1-5
228. Reiner NE (1994) Altered cell signaling and monocular phagocytic deactivation during intracellular infection. Immunol Today 15:374-381
229. McCabe RE, Remington JS (1990) Toxoplasma gondii. In: Mandell GL, Douglass R Jr, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, pp 140-260
230. Jones TC, Yeh S, Hirsch JG (1972) The interaction between Toxoplasma gondii and mammalian cells. Mechanism of entry and intracellular fate of the parasite. J Exp Med 136:1157-1172
231. Wilson CB, Remington CS (1979) Activity of human blood leukocytes against Toxoplasma gondii. J Infect Dis 140:890-895
232. Wilson CS, Tsai V, Remington JS (1980) Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med 151:328-346
233. Miller MJ, Aronson WJ, Remington JS (1969) Late parasitemia in asymptomatic acquired toxoplasmosis. Ann Intern Med 71:139-145
234. Remington JS, Melton ML, Jacobs L (1961) Induced and spontaneous recurrent parasitemia in chronic infections with avirulent starins of Toxoplasma gondii. J Immunol 87:578-581
235. Huldt G (1963) Experimental toxoplasmosis. Parasitaemia in guinea pigs. Acta Pathol Microbiol Scand 58:457-470
236. Meenken C, Assies J, Nieuwenhuizen O van et al (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581-584
237. Roitt IM (1997) Roitt's essential immunology. Blackwell, London, pp 276-281
238. Hafizi A, Modabber FZ (1978) Effect of cyclophosphamide in Toxoplasma gondii infection: reversal of the effect by passive immunization. Clin Exp Immunol 33:389-394
239. Coutinho SG, Leite MA, Amendoeira MR, Marzochi MC (1982) Concomitant cases of acquired toxoplasmosis in children of a single family: evidence of reinfection. J Infect Dis 146:30-33
240. Norrby R, Eilard T (1976) Recurrent toxoplsmosis. Scand J Infect Dis 8:275-276
241. Desmonts G (1966) Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76:383-386
242. De Boer JH, Verhagen C, Buinenberg M et al (1996) Serological and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 121:650-658
243. Minihan M, Cleary PE, Cryan B, Holliman R (1999) Diagnosis of an atypical case of ocular toxoplasmosis using the demonstration of intraocular antibody production and polymerase chain reaction. Br J Ophthalmol 83:753-758
244. Ronday MJ, Ongkosuwito JV, Rothova A, Kijlstra A (1999) Intraocular anti-toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol 127:294-300
245. Davidson MG, Lappin MR, English RV, Tompkins MB (1993) A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci 34:3653-3660
246. Karim A, Ludlam GB (1975) The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis. J Clin Pathol 28:42-49
247. Paul M (1999) Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosis. Clin Diagn Lab Immunol 6:514-518
248. Naol Y, Guotill DR, Remington JS Duration of IgM antibodies to Toxoplasma gondii after acute acquired toxoplasmosis.
249. Norrby R, Eilard T (1976) Recurrent toxoplasmosis. Scand J Infect Dis 8:275-276
250. Janitschke K, Senk U, Haffman HG, Dempe S (1989) Detection of Toxoplasma IgG and IgM antibodeis by enzyme-linked immunosorbent assay. Z Geburtshilfe Perinatal 193:203-307
251. Araujo FG, Remington JS (1972) Immune response to intracellular paraites: suppression by antibody. Proc Soc Exp Biol Med 139:254-257
252. Pinon JM, Chelma C, Villena I et al (1996) Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgG immunocapture and implications for postnatal strategies. J Clin Microbiol 34:579-583
253. Smolin G, Thoft (1994) The cornea. Scientific Foundations and Clinical Practice. Little Brown, Boston, pp 307-309
254. Husband HJ, Gowan JG (1978) The origin and antigen dependent distribution of Ig-A containing cells in the intestine. J Exp Med 148:1146
255. Tomasi TB (1980) Overview of the IgA system and its role in mucosal disease. In: O'Connor GR (ed) Immunologic diseases of the mucous membranes. Masson, New York, pp 1-10
256. Ronday MJ, Ongkosuwito JV, Rothova A, Kijlstra A (1999) Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol 127:294-300
257. Labalette P, Delhaes L, Margaron F, Fortier B, Rouland J (2002) Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 133:506-515
258. Stavnezer J (1995) Regulation of antibody production and switching by TGF-beta. J Immunol 155:1647-1651
259. Foudrinier T, Marx C, Aubert D et al (1995) Value of specific immunoglobulin. A detection by two immunocapture assays in the diagnosis of toxoplasmosis. Eur J Clin Microbiol Infect Dis 14:585-590
260. Pinon JM, Thoannes H, Pouletty PH, Poirriez J, Damients J, Pelletier P (1986) Detection of IgA specific for toxoplasmosis in serum and cerebrospinsal fluid using non-enzymatic IgA capture assay. Diagn Immunol 4:223-227
261. Hennequin C, Dureau P, N'Guyen L et al (1997) Congenital toxoplasmosis acquired from an immune woman. Pediatr Infect Dis J 16:75-77
262. Fortier B, Aissa E, Ajana F et al (1991) Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet 338:444
263. Dollfus H, Dureau P, Hennequin C et al (1998) Congenital toxoplasma chorioretinitis transmitted by preconceptionally immune women. Br J Ophthalmol 82:1444-1448
264. Anonymous (1990) Cell-mediated immunity and resistance to infection. Report of a WHO scientific group. WHO Tech Rep Ser 519:64
265. Anderson Se Jr, Krabenbuhl JL, Remington JS (1979) Longitudinal studies in lymphocyte response to Toxoplasma antigen in humans infected with T. gondii. J Clin Lab Immunol 2:293-297
266. Denkers EY, Gazinelli RT (1993) CD8+ T cell interactions with T. gondii: implication for processing of antigen for class-I restricted recognition. Res Immunol 144:51-57
267. Gazinelli RT, Hakim FT, Hieny S, Shearer GM, Sher CC (1991) Synergystic role of CD4+ and CD8+ T lymphocytes in IFN- production and protective immunity induced by T. gondii vaccine. J Immunol 146:286-292
268. Kasper LH, Buzoni-Gatel D (1998) Some opportunistic infection in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parsitol Today 14:150-156
269. Herion P, Saavedra R (1993) Human T cell clones as tools for the characterization of cell-mediated immune response to Toxoplasma gondii. Res Immunol 144:48-51
270. Suzuki Y, Remington JS (1988) Dual regulation of reisistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4 T cells in mice. J Immunol 140:3943
271. Khan IA, Smitch KA, Kasper LH (1988) Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol 14:3600
272. Joynson DHM (1999) Emerging parasitic infections in man. Infect Dis Rev Med Vet Environ 1:131-134
273. Rabaud C, May T, Lucet JC et al (1996) Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French national survey. Clin Infect Dis 23:1249-1254
274. Lieseneld O, Kasek JC, Suzuki Y (1997) Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. Infect Immun 65:4682-4689
275. Wong B, Park CG, Choi Y (1997) Indentifying the molecular control of T-cell death; on the hunt for killer genes. Semin Immunol 9:7-16
276. Hu MS, Schwartman JD, Yeaman GR, Collins J, Seguin R, Khan IA, Kasper LH (1999) Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun 67:928-935
277. Mets MB, Holfels E, Boyer KM et al (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309-324
278. Hutchison JH, Lee WR, Siim JC (1982) A study of cataract in murine congenital toxoplasmosis. Ann Trop Med Parasitol 76:53-70
279. Hay J, Hutchison WM, Lee WR, Siim JC (1981) Cataract in mice congenitally infected with Toxoplasma gondii. Ann Trop Med Parasitol 75:455-457
280. Eichenwald HG (1960) A study of congenital toxoplasmosis, with particular emphasis on clinical manifestation, sequelae and therapy: In: Siim JC (ed) Human toxoplasmosis. Munksgaard, Copenhagen, pp 41-49
281. Koppe JG, Loewer-Sieger DH, Roever-Bonnet H de (1986) Results of 20 year follow-up of congenital toxoplasmosis. Lancet I:254-256
282. Coureur J, Desmonts G, Tournier G, Szusterkac M (1984) Study of a homogenous series of 210 cases of congenital toxoplasmosis in infants aged 0-11 months detected prospectively. Ann Pediatr 31:815-819
283. McAuely JB, Boyer KM, Patel D et al (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment trial. Clin Infect Dis 18:38-72
284. Iijima H, Tsukahara Y, Imasawa M (1995) Angiographic findings in eyes with active ocular toxoplasmosis. Japn J Ophthalmol 39:402-410
285. Auer C, Bernasconi O, Herbort CP (1999) Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina 19:22-29
286. Davidson MG, Lappin MR, English RV, Tompkins MB (1993) A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci 34:3653-3660
287. Rothova A (1993) Ocular involvement in toxoplasmosis. Perspective. Br J Ophthalmol 77:371-377
288. Pavesio CEN, Belfort R Jr, Freitas D, Abro MT (1987) Toxoplasmose ocular: enigma a espera de estudos clinicos adequados. Arq Bras Oftalmol 50:91-93
289. Berengo A, Frezzotti R (1962) Active neuro-ophthalmic toxoplasmosis. Bibl Ophthal 59:265-343
290. Heimann K (1972) The development of the blood vessels of the macular choroid (abstract). Surv Ophthalmol 17:142
291. Freidman CT, Knox DL (1969) Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81:481-483
292. Doft BH, Gass DM (1985) Punctate outer retinal toxoplasmosis. Arch Ophthalmol 103:1332-1336
293. Matthews JD, Weiter JJ (1985) Outer retinal toxoplasmosis. Arch Ophthalmol 103:941-946
294. Silveira CM, Belfort R Jr, Nussenblatt R et el (1989) Unilateral pigmentary retinopathy associated with ocular toxoplasmosis. Am J Ophthalmol 107:682-684
295. Hogan MJ, Kimura SJ, O'Connor GR (1964) Ocular toxoplasmosis. Clin Sci 72:592-600
296. Chesterton JR, Perkins ES (1967) Ocular toxoplasmosis among Negro immigrants in London. Br J Ophthalmol 51:617-621
297. Tessler HH (1981) Ocular toxoplasmosis. Int Ophthalmol Clin 21:185-189
298. La Heig, Rothova A (1991) Fuch's heterochromic cyclitis in congenital ocular toxoplasmosis. Br J Ophthalmol 75:372-373
299. De Abreu, Belfort R, Hirata PS (1982) Fuch's heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 93:739-744
300. Schwab IR (1991) The epidemiologic association of Fuch's heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111:356-362
301. O'Connor GR (1970) The influence of hypersensitivity on the pathogenesis of ocular toxoplasmosis. Trans Am Ophthal Soc 68:501-547
302. O'Connor GR (1974) Manifestations and management of ocular toxoplasmosis. Bull NY Acad Med Soc II 50:192-210
303. Schuman JS, Weinberg RS, Ferry AP, Guerry RK (1988) Toxoplasmic scleritis. Ophthalmology 95:1399-1403
304. Wilder HC (1952) Toxoplasma chorioretinitis in adults. Arch Ophthalmol 48:127-136
305. Morgan CM, Gragoudas ES (1987) Branch retinal artery occlusion associated with recurrent toxoplasmic retinochoroiditis. Arch Ophthalmol 105:130-131
306. Braunstein RA, Gass JDM (1980) Branch artery obstruction caused by acute toxoplasmosis. Arch Ophthalmol 98:512-513
307. Gentile RC, Berinstein DM, Oppenheim R, Walsh JB (1997) Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis. Can J Ophthalmol 32:354-358
308. Goeffrey RE (1991) Papillitis, retinal neovascularization and recurrent vein occlusion in Toxoplasma retinochoroiditis: a case report with uncommon clinical signs. Aust NZ J Ophthalmol 19:155-157
309. Kyrieleis W (1933) Uber atypissch Gefatuberkulose der Netzhaut (Periarteritis nodosa tuberculoma). Arch Augenheilkd 182-190
310. Gass DM (1987) Stereoscopic atlas of macular disease: diagnosis and treatment, 3rd edn. Mosby, St Louis, pp 464-469
311. Meenken C, Assies J, Van Nieuvenhuizen O et al (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581-584
312. Holland GN, Engstrom RE, Berger BJ (1988) Ocular toxoplasmosis in patients acquired immunodeficiency syndrome (abstract). Am J Ophthalmol 106:653-667
313. Folk JC, Lobes LA (1984) Presumed toxoplasmic papillitis. Ophthalmology 91:64-67
314. Willerson D Jr, Aaberg TM, Reeser F, Meredith TA (1977) Unusual ocular presentations of acute toxoplasmosis. Br J Ophthalmol 61:693-698
315. Fish RH, Hoskins JC, Kline LB (1993) Toxoplasmic neuroretinitis. Ophthalmology 100:1177-1182
316. Reo JH, Jokobiec FA, Iwamoto T, Richard G, Kreissig I (1983) Opportunistic toxoplasmic retinochoroiditis following chemotherapy for systemic lymphoma. Ophthalmology 90:885-898
317. Michelson JB (1994) Uveitis and systemic disease. Curr Opin Ophthalmol 111:89-96
318. Manchot WA, Deemen CBF (1965) Connatal ocular toxoplasmosis. Arch Ophthalmol 74:48-56
319. Gross Niklaus HE, Specht CS, Allaire G, Leavitt JA (1990) Toxoplasma gondii retinochoroiditis and optic neuritis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 97:1342-1346
320. Mayes J, O'Connor BT, Avery R et al (1995) Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 21:511-515
321. Tirard V, Neil G, Rosenheim M, Katlama C, Ciceron L, Ogunkolade W, Danis M, Gentilini M (1991) Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood. N Engl J Med 324:634
322. Gagluiso DJ, Teich SA, Friedman AH et al (1990) Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc 88:63-86
323. Parke DW, Font RL (1986) Diffuse toxoplasmic retinochoroiditis in patients with AIDS. Arch Ophthalmol 104:1986
324. Moorthy RS, Smith RE, Rao NA (1993) Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 115:742-747
325. Berger BB, Egwuagu CE, Freeman WR, Wiley CA (1993) Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome. Arch Ophthalmol 115:742-747
326. Henin D, Duyckaerts C, Chaunu MP, Vazeaux RM, Brousse N, Rozenbaum W, Hauw JJ (1987) Etude neuropathologique de 31 cas de syndrome d'immunodepression acquise. Rev Neurol (Paris) 143:631
327. Alonso R, Heiman-Patterson T, Mancall EL (1984) Cerebral toxoplasmosis in acquired immune deficiency syndrome. Arch Neurol 41:321
328. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Pasner JB (1983) Neurological complications of acquired immune deficiency syndrome. Analysis of 50 patients. Ann Neurol 14:403
329. Hogan MG (1951) Ocular toxoplasmosis. Colombia University Press, New York
330. Tabbara KF (1992) Toxoplasmosis. In: Tasman W, Jaeger EA (eds) Duane clinical ophthalmology. Lippincott, Philadelphia, pp 1-23
331. Green WR (1996) Toxoplasmosis. In: Spencer WH (ed) Ophthalmic pathology. An atlas and textbook, 4th edn. Saunders, Philadelphia, pp 825-835
332. Smith RE, Nozik (1989) A clinical approach to diagnosis and management, 2nd edn. Williams and Wilkins, Baltimore, pp 128-132
333. Opremcak EM (1994) A clinical manual for ocular inflammation. Springer Verlag, New York, Berlin Heidelberg, pp 159-162
334. Zimmerman LE (1961) Ocular pathology of toxoplasmosis. Surv Ophthalmol 6:832-856
335. Holland GN, O'Connor GR, Belfort R, Remington JS (1996) Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection and immunity. Mosby Year Book, St Louis, pp 1183-1223
336. Nicholson DH, Wolchock EB (1976) Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch Ophthalmol 94:248-254
337. Heath P, Zuelzer WW (1944) Toxoplasmosis (report of eye findings in infant twins). Trans Am Ophthalmol Soc 42:119-131
338. Bamatter F (1947) La chorioretinite toxoplasmique. Ophthalmologica 114:340-358
339. Koch FLP, Wolf A, Cowen D et al (1943) Toxoplasmic encephalomyelitis. VII. Significance of ocular lesions in the diagnosis of infantile or congenital toxoplasmosis. Arch Ophthalmol 29:1-25
340. Binkhorst CD (1948) Toxoplasmosis. Report of four cases, with demonstration of parasites in one case. Ophthalmologica 115:65-67
341. Hogan MJ (1947) Toxoplasmic chorioretinitis. Trans Pac Coast Otoophthalmol Soc 28:83-102
342. Goebel S, Luder CG, Lugert R, Bohne W, Gross U (1998) Toxoplasma gondii inhibits the in vitro induced apoptosis of HL-60 cells. J Exp Clin Med 23:351-356
343. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ (1998) Toxoplasma gondii infected cells are resistant to multiple inducers of apoptosis. J Immunol 160:1824-1830
344. Strittmatter C, Lang W, Wiestler OD, Kleinhues P (1992) The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol (Berl) 83:475-481
345. Stavin MA, Meyers JD, Remington JS, Hackman RC (1994) Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 13:549-557
346. Rehder JR, Burnier M Jr, Pavesio et al (1988) Acute unilateral toxoplasmic iridocyclitis in an AIDS patient. Am J Ophthalmol 106:740-741
347. Hitchings GH, Burchall JJ (1965) Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol 27:417-468
348. WHO Model Prescribing Information (1990) Drugs used in parasitic diseases WHO Publication, pp 52-59
349. Engstrom RE, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601-610
350. McCabe RE, Oster S (1989) Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 38:937-987
351. Pedersen B (1992) Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis 84[Suppl]:23-31
352. Fortier B, Ajana E, Pinto de Sausa et al (1991) Prevention and treatment of materno-fetal toxoplasmosis. Press Med 20:1374-1383
353. Williams M, Savage DCL (1978) Acquired toxoplasmosis in children. Arch Dis Child 53:829
354. Norby R, Eilard T, Svedhem A, Lycke E (1975) Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole. Scand J Infect Dis 7:72-75
355. Reeves DS, Wilkinson PJ (1979) The pharmacokinetics of trimethoprim and trimethoprim/sulphinamide combination, including penetration into body tissues. Infection 7[Suppl 4]:330-341
356. Fernandez-Martin J, Leport C, Morlat P, Meyohas M, Chauvin J, Vilde JL (1991) Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrobial Agents Chemother 35:2049-2052
357. Lacassin F, Schaff OD, Perronne C, Longuet P, Leport C, Vilde JL (1995) Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 39:276-277
358. Piens MA, Garin JP (1989) New perspective in the chemoprophylaxis of toxoplasmosis. J Chemother 1:46-51
359. Leport C, Raffi F, Matheron S et al (1988) Treatment of central nervous system toxoplasmosis with pyrimethamine-sulphadiazine combination in 35 AIDS patients. Effect of long-term continuous therapy. Am Med J 84:94
360. Hacker M, Richter R, Gumbel H, Richter T, Ohrloff C (1998) Toxoplasmosis retinochoroiditis, a therapy comparison between spiramycin and pyrimethamine/sulphadiazine. Klin Monatsbl Augenheilk 212:84-87
361. Remington JS, Vilde JL (1991) Clindamycin for toxoplasma encephalitis in AIDS. Lancet 338:1142-1143
362. Luft BJ, Hafner R, Korzun A et al (1993) Toxplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329:995-1000
363. Tabbara KF, O'Connor GR (1980) Treatment of toxoplasmosis with clindamycin and sulphadiazine. Ophthalmology 87:129-134
364. Dhiver C, Milandre C, Poizot-Martin I, Dragoul J, Gastaut JL, Gastaut JA (1993) Fluoro-uracil-clindamycin for treatment of cerebral toxoplasmosis. AIDS 7:143-144
365. Luft BJ, Remington JS (1988) Toxoplasmic encephalitis. J Infect Dis 157:1-6
366. Norby A (1978) A review of the penetration of antibiotics into CSF and its clinical significance. Scand J Infect Dis 14:296-309
367. Martinez CE, Zhang D, Conway MD, Peyman GA (1998-1999) Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulphadiazine. Int Ophthalmol 22:85-88
368. Ferguson JG (1981) Clindamycin therapy for toxoplasmosis. Ann Ophthalmol 13:95-100
369. Davidson MG, Lappin MR, Tottman JR, Tompkins MB, English RV, Bruce AT, Jayawicknama J (1996) Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrob Agents Chemother 40:1352-1359
370. Huskinson-Mark J, Araujo FG, Remington M et al (1991) Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 164:170-177
371. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T et al (1996) Distribution of azithromycin into brain tissue, cerebrospinal fluid and aqueous humor of the eye. Antimicrob Agents Chemother 40:825-826
372. Wynn RF, Leen CLS, Brettle RP (1993) Azithromycin for cerebral toxoplasmosis in AIDS. Lancet 341:243-244
373. Saba J, Morlat P, Raff F, Hazebroucq V, Joly V, Leport C, Vilde JL (1993) Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur J Clin Microbiol Infect Dis 12:853-856
374. Rothova A, Bosch-Driessen LEH, Loon NH van, Treffers WF (1998) Azithromycin for ocular toxoplsmosis. Br J Ophthalmol 82:1306-1308
375. Morris JT, Kelly JW (1992) Effective treatment of cerebral toxoplasmosis with doxycycline. Am J Med 93:107-108
376. Johnson MW, Greven CM, Jaffe GJ, Sudhalkar H, Vine AK (1997) Atypical severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48-57
377. Gormely PD, Pavesio CE, Minnasian D, Lightman S (1998) Effect of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 39:1171-1175
378. Pearson PA, Piracha AR, Sen HA, Jaffe GJ (1999) Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106:148-153
379. Hughes WT (1995) The role of atovaquone in treating Pneumocystis carinii penumonia. J Acquir Immune Defic Syndr Hum Retrovirol 8:247-252
380. Khan AA, Slifer TR, Araujo FG, Remington JS (2001) Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii. Antimicrob Agents Chemother 45:48-51
381. Khan AA, Slifer T, Araujo FG, Polzer RJ, Remington JS (1997) Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Antimicrob Agents Chemother 41:893-897
382. Khan AA, Slifer T, Araujo FG, Remington JS (1996) Trovafloxacin is active against Toxoplasma gondii. Antimicrob Agents Chemother 40:1855-1859
383. Hegab S, Al-Mutawa S (2000) Immunopathogenesis of Behcet's disease: short analytical review. Clin Immunol 96:174-186
384. Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis. Fundamentals and Practice, 2nd edn. Mosby, St. Louis, pp 99-106
385. Balow JE, Rosenthal AS (1989) Gluococorticoid suppression of macrophage migration inhibition factor. J Exp Med 137:1031-1041
386. Kaplan MP, Lysz K, Rosenberg S, Rosenberg JC (1983) Suppression of interleukin-2 production by methylprednisone. Transplant Proc 15:407-410
387. Auphan N, diDianato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids. Inhibition of NKKB activity through induction of IKB synthesis. Science 270:286-290
388. Santos AA, Sheltinga MR, Lynch E et al (1993) Elaboration of interleukin-1 antagonists is not attenuated by glucocorticoids after toxemia. Arch Surg 128:138-144
389. Bosch-Driessen EH, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Commentary. Br J Ophthalmol 82:858-860
390. Hofflin JM, Conley FK, Remington JS (1987) Murine model of intracerebral toxoplasmosis. J Infect Dis 155:550-556
391. Sumyuen MH, Garin YJF, Derouin F (1996) Effect of immunosuppressive drug therapy on acute and murine toxoplasmosis. Parasitol Res 82:681-686
392. Stahl W, Matsubayashi H, Akao S (1966) Modification of subclinical toxoplasmosis in mice by cortisone, 6-mercaptopurine and splenectomy. Am J Trop Hyg 15:869-874
393. Kaufman HE (1960) The effect of corticosteroids on experimental toxoplasmosis. Am J Ophthalmol 50:919-925
394. Frenkel JK, Nelson BM, Arias-Stella J (1975) Immunosuppression and toxoplasmic encephalitis, clinical and experimental aspects. Hum Pathol 6:97-111
395. Chinchill A, Guerreo OM, Catarinella G et al (1993) Natural and induced blood dissemination of Toxoplasma gondii: experimental model in white mice and hamsters. Rev Biol Trop 41:197-202
396. Frenkel JK (1956) Pathogenesis of toxoplasmosis and infections with organisms resembling Toxoplasma. Ann NY Acad Sci x:215-251
397. Odaert H, Soete M, Fortier B et al (1996) Stage conversion of Toxoplasma gondii in mouse brain during infection and Immunosuppression. Parasitol Res 82:28-31
398. Morhun PJ, Elias SJ, Holland GN (1996) Recurrent toxoplasmosis in patients treated with systemic corticosteroids. Retina 16:383-387
399. Tismit JC, Bloch-Michel E (1987) Efficacite de la chimiotherapie specifique dans la prevention des recidives de chorioretinites toxoplasmiques dan les quatre annees qui suivent le traitment. J Fr Ophthalmol 10:15-23
400. Pauleikhoff D, Messmer E, Beelon DW et al (1987) Bone marrow transplantation and toxoplasmic retinochoroiditis. Graefes Arch Clin Ophthalmol 225:239-243
401. Gallino A, Maggiorini M, Kiowski W et al (1996) Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 14:389-393
402. Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28:58-61
403. Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517-523
404. Fajardo RV, Furgiuelle FP, Leopold IH (1962) Treatment of toxoplasmosis uveitis. Arch Ophthalmol 67:712-720
405. Ghosh M, Levy PM, Leopold IH (1963) Therapy of toxoplasmosis uveitis. Am J Ophthalmol 68:55-61
406. Cochereau-Massin I, Le Hoang P, Lautier-Frau M et al (1992) Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol 114:130-135
407. Damms T, Bohnke M, Behrend-Berdin B (1993) Ergebnisso der therapie bei okularer toxoplasmose. Ophthalmologe 90:737-741
408. Stray-Pedersen B (1992) Treatment of toxoplasmosis in the pregnant mother and new born child. Scand J Infect Dis 84[Suppl]:23-31
409. Ronday MJH, Luyendijk, Baarsma GS et al (1995) Presumed acquired ocular toxoplasmosis. Arch Ophthalmol 113:1524-1529
410. Benson MT, Parsons MA, Talbot JF et al (1992) Aggressive toxoplasma retinitis. Acta Ophthalmol (Copenh) 70:795-800
411. Holland GN, Engstrom RE, Glasgow BJ et al (1988) Ocular toxoplasmsosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 106:653